Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-26 @ 12:02 AM
NCT ID:
NCT03770494
Pre Assignment Details:
Completers included participants who died from any cause.
Recruitment Details:
* Phase 1a was a dose escalation phase with a starting dose of LY3405105 1 milligram (mg) once daily (Part A1) or 2 mg three times per week (Part A2) on a 28-day cycle until confirmed progressive disease, unacceptable toxicity, or discontinuation for any other reason. Each dose level will have minimum of 3 participants enrolled.
* Phase 1b was a dose expansion phase which was planned but not initiated based on sponsor's decision and limited efficacy observed in phase 1a. No participants enrolled.
Study:
NCT03770494
Study Brief:
Results Section:
NCT03770494